Results from Long COVID trial published
Blog
At Drug Science we like to cover different topics relating to drugs. These topics cover the many different ways that psychoactive substances have an impact on our culture and society.
UK’s largest medical cannabis study announces new industry partners
Know Your Rights: Medical Cannabis
Mike Roberts – Medical Cannabis Patient Story
Sophie Gorman – Medical Cannabis Patient Story
The Drug Science Podcast and Medical Cannabis
Impact of the introduction of medical cannabis in the UK on risk perception and recreational use of cannabis: A longitudinal and cross-sectional analysis
Medicinal cannabis for pain: Real-world data on three-month changes in symptoms and quality of life
Combating the stigma: a T21 success story
Parents and scientists back new study into benefits of cannabis-based medications for children with severe epilepsy
UK’s First Medical Cannabis Patient Conference
The value of real world evidence: The case of medical cannabis
Cannabinoids and the endocannabinoid system in fibromyalgia: a review of preclinical and clinical research
Characteristics of People Seeking Prescribed Cannabinoids for the Treatment of Chronic Pain: Evidence From Project Twenty 21
Are you looking for more information about our Long COVID study?
Farmability and pharmability: Transforming the drug market to a health-and human rights-centred approach from self-cultivation to safe supply of controlled substances
Medical Cannabis Prescribing for GPs
Drug Science will study the benefits of medical cannabis for patients with Long COVID
Why doctors have a moral imperative to prescribe and support medical cannabis—an essay by David Nutt
Project Twenty21 in 2022: A Message for Patients
Medical cannabis for severe treatment resistant epilepsy in children: a case series of 10 patients